Literature DB >> 21377938

Mortality in elderly patients with hyperostotic disease of the cervical spine after fracture: an age- and sex-matched study.

Andrew J Schoenfeld1, Mitchel B Harris, Kevin J McGuire, Natalie Warholic, Kirkham B Wood, Christopher M Bono.   

Abstract

BACKGROUND CONTEXT: Several reports indicate that patients with ankylosing spondylitis (AS) and diffuse idiopathic skeletal hyperostosis (DISH) have increased mortality after cervical spine fractures. However, outcomes of the fractured hyperostotic cervical spine are incompletely described, and there are limited data regarding the covariable effects of patient age and medical comorbidities on mortality.
PURPOSE: To determine mortality associated with cervical fractures in patients with hyperostotic disease. STUDY
DESIGN: Retrospective case-control study. PATIENT SAMPLE: Forty-three patients identified through a registry as having fractures of the cervical spine in the setting of hyperostotic disease. These patients were matched to 43 controls who did not carry the diagnosis of hyperostotic disease. OUTCOME MEASURES: Mortality at 3 months and 1, 2, and 3 years after fracture.
METHODS: An institutional database was used to identify all cervical fractures sustained by patients aged 65 years and older from 1991 to 2006. Demographic information, date of injury, associated injuries, treatment type, presence of AS or DISH, and comorbidities were abstracted from medical records and radiographs. Mortality was ascertained using the National Death Index. Patients with AS or DISH were matched to controls who did not carry the diagnosis of hyperostotic disease. Risks of mortality were calculated at 3 months, 1 year, 2 years, and 3 years. Kaplan-Meier methods, logistic regression analysis, the two independent sample t test, and the Fisher exact test were used to compare mortalities between the two groups. Statistical significance was determined as p values <.05.
RESULTS: Forty-three patients were identified as having fractures in the setting of hyperostotic disease of the cervical spine. Twenty-seven individuals had DISH, and 16 had AS. The average age of both the study group and controls was 80 years, with an age range of 68 to 94. There was no significantly increased risk of mortality between the overall study group and control group at 3 months (p=.20), 1 (p=.22), 2 (p=.15), or 3 years (p=.50) after injury. Compared with controls, subgroup analysis of patients with AS showed a statistically increased risk of mortality at 3 months (p<.01) and at 1 and 2 years (p<.01 at both time points). When compared with individuals with DISH, those with AS had an increased risk of mortality at time points up to 2 years after fracture. Patients with DISH did not have an increased mortality risk at any time point when compared with controls.
CONCLUSIONS: The effect of fracture on mortality appears to be greatest in those with AS. Patients with DISH did not demonstrate an increased risk of mortality compared with age- and sex-matched controls. Future studies of patients with hyperostotic disease should analyze patients with DISH and AS separately instead of as a single homogenous group. LEVEL OF EVIDENCE: Level IV. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21377938     DOI: 10.1016/j.spinee.2011.01.018

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  9 in total

1.  An Analysis of Patient and Fracture Characteristics and Clinical Outcomes in Patients With Hyperostotic Spine Fractures.

Authors:  David N Bernstein; Daren J McCalla; Robert W Molinari; Paul T Rubery; Emmanuel N Menga; Addisu Mesfin
Journal:  Global Spine J       Date:  2019-11-12

2.  Surgical management of spinal fractures in ankylosing spondylitis.

Authors:  Etka Kurucan; David N Bernstein; Addisu Mesfin
Journal:  J Spine Surg       Date:  2018-09

3.  Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden.

Authors:  Yohan Robinson; Bengt Sandén; Claes Olerud
Journal:  Patient Saf Surg       Date:  2013-01-07

4.  Thoracic and lumbar vertebral bone mineral density changes in a natural occurring dog model of diffuse idiopathic skeletal hyperostosis.

Authors:  Steven De Decker; Richard Lam; Rowena M A Packer; Ingrid M V L Gielen; Holger A Volk
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

5.  Odontoid Fracture in a Patient With Diffuse Idiopathic Skeletal Hyperostosis.

Authors:  Adan Omar; Addisu Mesfin
Journal:  Geriatr Orthop Surg Rehabil       Date:  2016-12-27

6.  The Relationship between the Occipitocervical Junction and Thoracic Kyphosis in Ankylosing Spondylitis: A Retrospective Cohort Study of 86 Cervical Fractures in Surgically Treated Patients.

Authors:  Nodoka Manabe; Augusto Covaro; Lukas Bobinski; Takachika Shimizu; Claes Olerud; Yohan Robinson
Journal:  Asian Spine J       Date:  2018-10-18

7.  Instantaneous death risk, conditional survival and optimal surgery timing in cervical fracture patients with ankylosing spondylitis: A national multicentre retrospective study.

Authors:  Jinfeng Huang; Hao Bai; Quanchang Tan; Dingjun Hao; Aimin Wu; Qingde Wang; Bing Wang; Linfeng Wang; Hao Liu; Xiongsheng Chen; Zhengsong Jiang; Xiaoming Ma; Xinyu Liu; Peng Liu; Weihua Cai; Ming Lu; Ningfang Mao; Yong Wang; Suochao Fu; Shuai Zhao; Xiaofang Zang; Youzhuan Xie; Haiyang Yu; Ruixian Song; Jiangbo Sun; Liangbi Xiang; Xiang Liu; Songkai Li; Bo Liao; Zixiang Wu
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

8.  Surgical Stabilization Improves Survival of Spinal Fractures Related to Ankylosing Spondylitis.

Authors:  Yohan Robinson; Johan Willander; Claes Olerud
Journal:  Spine (Phila Pa 1976)       Date:  2015-11       Impact factor: 3.468

9.  A Comparison of Cervical and Thoracolumbar Fractures Associated with Diffuse Idiopathic Skeletal Hyperostosis-A Nationwide Multicenter Study.

Authors:  Hiroyuki Katoh; Eijiro Okada; Toshitaka Yoshii; Tsuyoshi Yamada; Kei Watanabe; Keiichi Katsumi; Akihiko Hiyama; Yukihiro Nakagawa; Motohiro Okada; Teruaki Endo; Kazuhiro Takeuchi; Shunji Matsunaga; Keishi Maruo; Kenichiro Sakai; Sho Kobayashi; Tetsuro Ohba; Kanichiro Wada; Junichi Ohya; Kanji Mori; Mikito Tsushima; Hirosuke Nishimura; Takashi Tsuji; Kota Watanabe; Morio Matsumoto; Atsushi Okawa; Masahiko Watanabe
Journal:  J Clin Med       Date:  2020-01-12       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.